News
Jun 2020
A new company has been formed to serve ApogeeFlow's growing customer base in the Asia-Pacific region.
Conveniently located in the heart of Hong Kong's renowned commercial district, Apogee Flow Asia Ltd. employs staff with many years of experience supporting ApogeeFlow cytometers. The launch of Apogee Flow Asia Ltd. is an important benchmark in ApogeeFlow's development and will provide facilities for demonstration, training and applications development.
Oct 2019
@Nanostics' ClarityDX Prostate clinical validation study is expanding into the US with the Century Clinical Research, Inc. recruitment site in Daytona Beach, FL. This expansion will significantly accelerate the clinical study timeline while increasing patient cohort diversity.
Nanostics have selected ApogeeFlow's platform for this program.
Key points:
- Nanostics is expanding its ClarityDX Prostate clinical validation study into the US by opening the Florid...
Jul 2019
ApogeeFlow and Nanostics will exhibit at the First ISEV & MRS Joint Extracellular Vesicle Conference focused on cancer.
Nashville, 2nd-4th August 2019
Jun 2019
This clinical study is being conducted with Apogee Microflow technology and in partnership with Apogee Flow Systems.
Nanostics Announces Launch of its Clinical Validation Study for ClarityDX Prostate
Nanostics Inc., a company developing a novel liquid biopsy platform for the early diagnosis of clinically significant prostate cancer, is pleased to announce the start of its key clinical validation study. The study will be carried out with blood to be sampled from 2,800 men with eleva...
May 2019
This year we will again exhibit at CYTO, this time in Vancouver.
June 22 - 26
// Read more...
// Read more...
// Read more...
// Read more...
// Read more...
